A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients

Photosensitive Epilepsy Clinical Trial

Official title:
A Phase 2a, Multi-center, Single-blind, Within-subject, Placebo-controlled Study to Assess the Pharmacodynamics of ACT-709478 in Subjects With Photosensitive Epilepsy

Status Completed

Clinical Trial Summary

The main study objective is to assess the effect of ACT-709478 in male and female subjects with photosensitive epilepsy following single dose administration

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03239691
Study type	Interventional
Source	Idorsia Pharmaceuticals Ltd.
Contact
Status	Completed
Phase	Phase 2
Start date	October 6, 2017
Completion date	April 25, 2018

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03686033` - A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy	Phase 2
Completed	`NCT00784212` - Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy	Phase 2
Completed	`NCT00579384` - A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy	Phase 2
Active, not recruiting	`NCT03790137` - Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).	Phase 3
Completed	`NCT00894010` - Photosensitivity Proof of Concept Trial	Phase 2
Completed	`NCT03580707` - Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint	Phase 2/Phase 3
Terminated	`NCT03603639` - A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy	Phase 2
Completed	`NCT00609245` - Effect of Valproic Acid Concentration on Photic Response	N/A